Thought Leadership
At SSI Strategy, we believe that knowledge is a key driver in building better biotechs. Our Insights provide valuable information and expert perspectives to empower biotech leaders like you.
Articles and White Papers
All services
Development Strategy
Medical Devices
Pharmacovigilance
NDA Advisory Board
Strategic Communications
Regulatory
Quality & Compliance
All expertise
Oncology
Vaccine
Immunogenicity
HTA
In-Vitro Diagnostics
Non-Clinical
Cell and Gene Therapy
Biostatistics
Cardiology
ATMP
Rare Disease
Market Access
CMC
Clinical
Paediatric
Acceleration Strategies
Medical Devices
Quality
Patient Safety
24-10-2025
Unannounced FDA Inspections: A Turning Point for Global GMP Compliance
This white paper outlines how to sustain readiness every day, not only during inspections, and the operational, cultural, and strategic steps that support continuous compliance.
18-09-2025
From Drafting to Directing: The AI Shift in Regulatory Document Generation
This white paper examines how AI is changing the way documents are created, reviewed, and delivered, and what this shift means for the future of regulatory affairs.
04-07-2025
Blueprint for Building a Medical Office
The blueprint offers a practical framework for early-stage biotechs going from zero to one—helping you focus on what matters, stay lean, and put the right pieces in place at the right time.
27-06-2025
A Strategic Integrated Development Plan: A Critical Component for Biotech Success
This whitepaper outlines how to build a CDP that supports both execution and evidence, connecting clinical strategy with regulatory requirements, payer expectations, and business goals from the outset.
18-06-2025
The EU HTA Regulation: Joint Scientific Consultation – Key Steps, Timing & Strategy
This session outlines the structure, timing, and strategic use of JSCs, providing insights into how sponsors can use this process to shape evidence planning, avoid misalignment, and strengthen their position for future JCA procedures.
27-03-2025
Integrated Medical Leadership: Moving Beyond the Fractional CMO Model
This whitepaper shares a smarter way to integrate medical and business strategies and how our tailored model can work for your organization.
LET'S TALK
You don't have to go it alone!
Our experienced team has been there before, and we're ready to guide you through the unknown.Share your challenges with us, and together, we'll create a plan to efficiently reach your milestones and turn your vision into reality.
Building Better Biotechs
